Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 228 (RNA5SP228) is a non-coding pseudogene in the human genome derived from the 5S ribosomal RNA gene family. Unlike canonical 5S rRNA, which is a 120-nucleotide RNA forming an essential part of the large ribosomal subunit for protein synthesis[1][3][5], pseudogenes such as RNA5SP228 are non-functional copies that arise through genomic duplication or retrotransposition. They lack the ability to be processed into mature, functional rRNA and are not typically transcribed or incorporated into ribosomes[4]. While some pseudogenes are transcribed and studied for their potential regulatory roles (such as acting as competing endogenous RNAs or influencing tumor biology)[2][6], most—including RNA5SP228—do not have confirmed biological function or disease association[4]. Pseudogenes are routinely annotated in genomic databases like GENCODE and Ensembl as rRNA_pseudogenes, indicating their origin and lack of protein-coding or canonical non-coding RNA function[4]. Functional 5S rRNA (not pseudogenes) is critical for ribosome assembly and protein translation, but this is not true of RNA5SP228[1][5]. There is no evidence that this pseudogene serves as a therapeutic target or biomarker. The presence of many 5S rRNA pseudogenes in the genome is a normal feature and does not indicate pathology[4]. Some studies suggest pseudogenes in general may have roles in gene regulation in cancer contexts, but this is not established for RNA5SP228 specifically[2].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 228 (RNA5SP228).